Our vision: individualize cancer medicine
IR Side Nav
Investor Contact Sylke Maas, Ph.D.
VP Investor Relations & Business Strategy
Investors@biontech.de
+49 6131 9084-0
VP Investor Relations & Business Strategy
Investors@biontech.de
+49 6131 9084-0
For U.S. Investors:
Westwicke
Victoria Meissner, M.D.
victoria.meissner@westwicke.com
+1 646 677-1837
Westwicke
Victoria Meissner, M.D.
victoria.meissner@westwicke.com
+1 646 677-1837
Media Contact Jasmina Alatovic
Senior Manager Global External Communications
Media@biontech.de
+49 6131 9084-1513
Senior Manager Global External Communications
Media@biontech.de
+49 6131 9084-1513
Overview
In this section you can find all materials related to our financial reporting
Latest Annual Report (20-F)
Latest Quarterly Report
Show all2020
Q2
- Q2 2020 Financial Report 314.6 KB
- Finanzbericht 2. Quartal 2020 344.3 KB
- Q2 2020 Presentation 2 MB
Latest SEC Filings
| Filing date | Description | Form | View |
|---|---|---|---|
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
| D | View HTML | ||
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML |
